LEUKEMIA

简称 LEUKEMIA ·ENGLAND ·出版周期 Monthly ·年均收录 203 篇

13.4

最新影响因子

5.20%

自引率

很难

投稿难度

一般,3-6周

审稿周期

期刊简介

LEUKEMIA是一本专注于白血病和相关血液疾病研究的国际学术期刊，ISSN号为0887-6924，由英国Nature Publishing Group出版，每月发行一次，出版地为英国。该期刊的影响因子较高，属于SCI收录期刊，并在中科院分区中通常位于医学或肿瘤学领域的较高分区。LEUKEMIA不是完全开放获取（OA）期刊，但部分文章可选择OA模式发表。其发文特点涵盖白血病的基础研究、临床治疗、分子机制及转化医学等领域，尤其关注前沿进展和创新疗法。杂志以高质量的同行评审和严格的学术标准著称，但投稿竞争激烈，拒稿率较高，对研究新颖性和方法学要求严格，因此投稿需确保研究具备较高的学术价值和创新性。总体而言，LEUKEMIA是血液病学领域的权威期刊，适合发表高水平研究成果，但需注意其审稿周期可能较长且发表门槛较高。

影响因子趋势

近期发表

Targeting PI3K decreases trogocytosis-mediated CAR T cell fratricide 2026-09-04

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia 2026-09-04

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms 2026-09-03

CD19-CAR T cells persist long-term in the cerebrospinal fluid of pediatric, adolescent and young adult patients with B-cell acute lymphoblastic leukemia 2026-09-03

Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy 2026-09-03

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma 2026-09-03

Jagged-dependent Notch signaling governs extracellular vesicle bioactivity in multiple myeloma 2026-09-02

KLF4/MLL3 complex axis drives NRBP2 transcription to eliminate acute myeloid leukemia cells 2026-09-02

Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach 2026-09-01

Association of sarcopenia with treatment tolerance in older adults with acute myeloid leukemia using artificial intelligence computed tomography–segmentation and a geriatric assessment 2026-08-31